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INTRODUCTION 
            Controlled drug delivery systems are investigated to increase the chemical 
stability of the drug and to eliminate the side effects caused by the systemic 
administration via the circulatory system. Functionalized silica and titania xerogels are 
emerging as a new category of drug host systems. In the treatment of neurological 
disorders, which occur primarily in the central nervous system, a ceramic device can 
be implanted directly near a damaged tissue, thus avoiding passage through the blood 
brain barrier and reducing the necessary drug doses. Valproic acid (VPA), an often 
used anticonvulsant drug, encapsulated within a titania device has been successfully 
tested on mice as a therapy for epileptic disorders and is necessary to understand how 
to control the kinetics of drug release by changing the synthesis parameters.  
EXPERIMENT AND RESULTS 
            Three different samples of TiO2-V PA were prepared with alkoxide:water 
molar ratios of 1:4, 1:8, and 1:16, with a constant alkoxide:solvent molar ratio (1:8) at 
30 mg VPA/g TiO2. VPA was dissolved in a mixture of t-butanol and water. Titanium 
n-butoxide was added drop-wise, maintaining the mixture under constant stirring at 30 
°C. The solution was stirred for 24 h. Finally, alcohol was evaporated and the titania-
VPA materials were dried at 30°C for three weeks. The Raman spectra of the powders 
were recorded with 632.8 nm light by a Jobin-Yvon Labram micro-Raman apparatus. 
The laser power on the sample was kept below 1 mW by the insertion of optical filters.  
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           The Raman spectra in the 2600-3000 cm  region (Fig. 1- left) show features 
due to the stretching C-H vibrations of -CH, -CH2, and -CH3 groups of VPA. In the 
730
low wave-number region (Fig.1- right), three broad bands typical of amorphous titania 
at about 200, 430, and 630 cm
-1 
are evident. Pure VPA shows a feature at 314 cm
-1
. 
The Raman spectra suggest that the crystals must be smaller than 5 nm for all three 







  FIGURE 1.  (a) High and (b) low frequency Raman spectra in TiO2-VPA system prepared at different 
alkoxide:water molar ratios. 
 
           Usually, sol-gel TiO2 synthesized under acid conditions at RT produces a 
mixture of the three forms of crystalline titania, i.e. brookite, anatase, and rutile: our 
results suggest that the addition of valproic acid seems to favour the formation of 
amorphous titania. Hydrogen bridges such as TiO–·HO=C–R could hinder the 
formation of crystallites. 
           The surface areas, obtained by BET measurements, are five times larger than 
those of conventional titania: the increased acidity of the initial sol produces larger 
pore sizes and areas in the final product, compatible with 5 nm nanosized titania as 
estimated by Raman measurements. The pore diameter and the surface concentration 
of hydroxyl groups control the rate of drug release. Titania surface hydroxylation 
should lead to greater interaction between titania and the valproic acid, thus decreasing 
the rate of drug release. Increasing the water/alkoxide ratio may lead to a decrease of 
surface hydroxylation and therefore to a reduction of titania drug interaction and to 
increasing rate of drug release from the titania reservoir. A further decrease in surface 
hydroxylation by increasing the water/alkoxide ratio is however accompanied by a 
decrease in pore size thus reducing the rate of drug release. 
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